Cas 357336-20-0
- Description
- Additional information
Description
| Product Name | Brivaracetam |
| Synonyms | Briviact;UCB-34714;brivaracetam;BrivaracetamL;API-Anti Epilepsy;Brivaracetam fandachem;brivaracetam USP/EP/BP;UCB 34714 |
| CAS NO | 357336-20-0 |
| Molecular Formula | C11H20N2O2 |
| Molecular Weight | 212.29 |
What is Brivaracetam?
Brivaracetam is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. It provides a new monotherapy treatment option for epilepsy patients 16 years of age and older who suffer partial-onset seizures, which can be initiated at a therapeutic dose on day one.
Packing material for different products: Aluminium foil bag, HDPE bottle, Iron drum, or according to require
Shelf Life: 2 Years from production date
Additional information
| Melting Point | 76.38° |
|---|---|
| Boiling point | 409.3±28.0 °C(Predicted) |
| Density | 1.062 |
| Solubility | DMSO (Slightly), Methanol (Slightly) |
| Color | White |
| Form | Powder |
Reviews
There are no reviews yet.